Artwork

内容由Bryn Mawr Communications (BMC) and Retina Today提供。所有播客内容(包括剧集、图形和播客描述)均由 Bryn Mawr Communications (BMC) and Retina Today 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

A Treatment With a Novel MOA for Patients With nAMD and DME: Perspectives From the Real World

34:24
 
分享
 

Manage episode 424500612 series 2134816
内容由Bryn Mawr Communications (BMC) and Retina Today提供。所有播客内容(包括剧集、图形和播客描述)均由 Bryn Mawr Communications (BMC) and Retina Today 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Recent studies have proven the therapeutic viability of a different approach in treating retinal vascular diseases. Join Dr. John Kitchens, Dr. Margaret Chang, and Dr. David Chin Yee as they discuss their clinical experiences using a therapy with a novel mechanism of action in patients with nAMD and DME. And, learn how they approach managing patients with macular edema. This special episode of New Retina Radio, and its content, is supported by Genentech USA, Inc.

  continue reading

178集单集

Artwork
icon分享
 
Manage episode 424500612 series 2134816
内容由Bryn Mawr Communications (BMC) and Retina Today提供。所有播客内容(包括剧集、图形和播客描述)均由 Bryn Mawr Communications (BMC) and Retina Today 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Recent studies have proven the therapeutic viability of a different approach in treating retinal vascular diseases. Join Dr. John Kitchens, Dr. Margaret Chang, and Dr. David Chin Yee as they discuss their clinical experiences using a therapy with a novel mechanism of action in patients with nAMD and DME. And, learn how they approach managing patients with macular edema. This special episode of New Retina Radio, and its content, is supported by Genentech USA, Inc.

  continue reading

178集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南